These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9202771

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Superoxide dismutase activity in cisternal cerebrospinal fluid after aneurysmal subarachnoid haemorrhage.
    Gaetani P, Cafe C, Rodriguez y Baena R, Tancioni F, Torri C, Tartara F, Marzatico F.
    Acta Neurochir (Wien); 1997; 139(11):1033-7. PubMed ID: 9442216
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
    Zhang Z, Nagata I, Kikuchi H, Xue JH, Sakai N, Sakai H, Yanamoto H.
    Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217
    [Abstract] [Full Text] [Related]

  • 6. Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid.
    Gaetani P, Rodriguez y Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P.
    J Neurol Neurosurg Psychiatry; 1994 Jan; 57(1):66-72. PubMed ID: 8301307
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Schebesch KM, Brawanski A, Bele S, Schödel P, Herbst A, Bründl E, Kagerbauer SM, Martin J, Lohmeier A, Stoerr EM, Proescholdt M.
    Neurol Res; 2013 Dec; 35(10):1038-43. PubMed ID: 23915659
    [Abstract] [Full Text] [Related]

  • 12. Effect of continuous cisternal cerebrospinal fluid drainage for patients with thin subarachnoid hemorrhage.
    Otawara Y, Ogasawara K, Kubo Y, Sasoh M, Ogawa A.
    Vasc Health Risk Manag; 2007 Dec; 3(4):401-4. PubMed ID: 17969369
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy.
    Miller CA, Lombard FW, Wu CT, Hubbard CJ, Silbajoris L, Borel CO, Niklason LE.
    Neurocrit Care; 2006 Dec; 5(3):215-21. PubMed ID: 17290093
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A study on cisternal CSF levels of arachidonic acid metabolites after aneurysmal subarachnoid hemorrhage.
    Rodriguez y Baena R, Gaetani P, Paoletti P.
    J Neurol Sci; 1988 Apr; 84(2-3):329-35. PubMed ID: 3132538
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.